HF
ESPR

HRT Financial’s Esperion Therapeutics ESPR Stock Holding History

HRT Financial’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-626,922
Closed -$1.72M – 4537
2026
Q1 		$1.72M Buy
626,922
+387,562
+162% +$1.23M ﹤0.01% 1719
2025
Q4 		$885K Buy
239,360
+81,499
+52% +$263K ﹤0.01% 1791
2025
Q3 		$418K Buy
+157,861
New +$305K ﹤0.01% 1985
2025
Q2 		– Sell
-669,829
Closed -$964K – 2878
2025
Q1 		$964K Buy
669,829
+109,284
+19% +$201K 0.01% 1123
2024
Q4 		$1.23M Buy
+560,545
New +$1.31M 0.01% 971
2024
Q2 		– Sell
-442,030
Closed -$1.18M – 2451
2024
Q1 		$1.18M Buy
442,030
+394,059
+821% +$958K 0.01% 807
2023
Q4 		$143K Sell
47,971
-18,799
-28% -$24.4K ﹤0.01% 1846
2023
Q3 		$65K Sell
66,770
-433,999
-87% -$628K ﹤0.01% 1986
2023
Q2 		$696K Buy
500,769
+481,346
+2,478% +$672K 0.01% 1176
2023
Q1 		$30K Sell
19,423
-433
-2% -$2.23K ﹤0.01% 2157
2022
Q4 		$123K Sell
19,856
-26,339
-57% -$188K ﹤0.01% 2033
2022
Q3 		$309K Buy
46,195
+12,729
+38% +$87.4K ﹤0.01% 1977
2022
Q2 		$212K Buy
+33,466
New +$190K ﹤0.01% 2223
2022
Q1 		– Sell
-235,475
Closed -$1.18M – 3289
2021
Q4 		$1.18M Buy
235,475
+50,791
+28% +$407K 0.01% 984
2021
Q3 		$2.23M Buy
+184,684
New +$2.69M 0.01% 668
2020
Q1 		– Sell
-6,825
Closed -$406K – 915
2019
Q4 		$406K Buy
+6,825
New +$307K 0.02% 608

Other funds holding ESPR

GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TC
Trium Capital London, United Kingdom $163M AUM 45.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.16B AUM 43.32% 1-Year Est. Return

HRT Financial's ESPR Position: Q2 2026 in Review

HRT Financial sold out of Esperion Therapeutics (ESPR) in Q2 2026, closing a stake of 626,922 shares — an estimated $1.72M sold.

HRT Financial first reported a position in ESPR in Q4 2019 and held it in 16 quarters. The position peaked at $2.23M in Q3 2021. 191 funds tracked by Wall St. Rank hold ESPR as of Q2 2026.

  • HRT Financial reported no remaining Esperion Therapeutics position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 626,922 Esperion Therapeutics shares in Q2 2026, an estimated $1.72M.
  • HRT Financial first reported a position in Esperion Therapeutics in Q4 2019 and held it in 16 quarters.
  • HRT Financial's Esperion Therapeutics position peaked at $2.23M in Q3 2021.
  • 191 funds tracked by Wall St. Rank held Esperion Therapeutics as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.